Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: A multicentre cohort studyResearch in context

Shaobo Mo; Weixing Dai; Hui Wang; Xiaoliang Lan; Chengcheng Ma; Zhixi Su; Wenqiang Xiang; Lingyu Han; Wenqin Luo; Long Zhang; Renjie Wang; Yaodong Zhang; Wenming Zhang; Lin Yang; Renquan Lu; Lin Guo; Ying Zheng; Mingzhu Huang; Ye Xu; Li Liang; Sanjun Cai; Guoxiang Cai

EClinicalMedicine (Jan 2023)

Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: A multicentre cohort studyResearch in context

Shaobo Mo,
Weixing Dai,
Hui Wang,
Xiaoliang Lan,
Chengcheng Ma,
Zhixi Su,
Wenqiang Xiang,
Lingyu Han,
Wenqin Luo,
Long Zhang,
Renjie Wang,
Yaodong Zhang,
Wenming Zhang,
Lin Yang,
Renquan Lu,
Lin Guo,
Ying Zheng,
Mingzhu Huang,
Ye Xu,
Li Liang,
Sanjun Cai,
Guoxiang Cai

Affiliations

Shaobo Mo: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Weixing Dai: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Hui Wang: Singlera Genomics (Shanghai) Ltd, Shanghai, China
Xiaoliang Lan: Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China
Chengcheng Ma: Singlera Genomics (Shanghai) Ltd, Shanghai, China
Zhixi Su: Singlera Genomics (Shanghai) Ltd, Shanghai, China
Wenqiang Xiang: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Lingyu Han: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Wenqin Luo: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Long Zhang: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Cancer Institute, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China
Renjie Wang: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Yaodong Zhang: Department of Intensive Care Unit, Fudan University Shanghai Cancer Center, Shanghai, China
Wenming Zhang: Department of Endoscopy, Fudan University Shanghai Cancer Center, Shanghai, China
Lin Yang: Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China
Renquan Lu: Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China
Lin Guo: Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China
Ying Zheng: Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Shanghai, China
Mingzhu Huang: Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
Ye Xu: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Corresponding author. Department of Colorectal Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Li Liang: Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Province Key Laboratory of Molecular Tumor Pathology, Southern Medical University, Guangzhou, China; Corresponding author. Department of Pathology, Nanfang Hospital, Southern Medical University; Guangdong Province Key Laboratory of Molecular Tumor Pathology, Southern Medical University, Guangzhou, China.
Sanjun Cai: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Cancer Institute, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China; Corresponding author. Department of Colorectal Surgery, Fudan University Shanghai Cancer Center; Department of Cancer Institute, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Guoxiang Cai: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Corresponding author. Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

Journal volume & issue: Vol. 55
p. 101717

Abstract

Read online

Summary: Background: Early detection and prognosis prediction of colorectal cancer (CRC) can significantly reduce CRC-related mortality. Recently, circulating tumour DNA (ctDNA) methylation has shown good application foreground in the early detection and prognosis prediction of multiple tumours. Methods: This multicentre cohort study evaluated ctDNA methylation haplotype patterns based on archived plasma samples (collected between 2010 and 2018) from 1138 individuals at two medical centres: Fudan University Shanghai Cancer Center (Shanghai, China) and Southern Medical University Nanfang Hospital (Guangzhou, Guangdong, China), including 366 healthy individuals, 182 patients with advanced adenoma (AA), and 590 patients with CRC. Samples were processed using the ColonES assay, a targeted bisulfite sequencing method that detects ctDNA methylation haplotype patterns in 191 genomic regions. Among these 1138 samples, 748 were used to develop a classification model, and 390 served as a blinded cohort for independent validation. The study is registered at https://register.clinicaltrials.gov with the unique identifier NCT03737591. Results: The model obtained from unblinded samples discriminated patients with CRC or AA from normal controls with high accuracy. In the blinded validation set, the ColonES assay achieved sensitivity values of 79.0% (95% confidence interval (CI), 66%–88%) in AA patients and 86.6% (95% CI, 81%–91%) in CRC patients with a specificity of 88.1% (95% CI, 81%–93%) in healthy individuals. The model area under the curve (AUC) for the blinded validation set was 0.903 for AA samples and 0.937 for CRC samples. Additionally, the prognosis of patients with high preoperative ctDNA methylation levels was worse than that of patients with low ctDNA methylation levels (p = 0.001 for relapse-free survival and p = 0.004 for overall survival). Interpretation: We successfully developed and validated an accurate, noninvasive detection method based on ctDNA methylation haplotype patterns that may enable early detection and prognosis prediction for CRC. Funding: The Grant of National Natural Science Foundation of China (No.81871958), National Natural Science Foundation of China (No. 82203215), Shanghai Science and Technology Committee (No. 19140902100), Scientific Research Fund of Fudan University (No.IDF159052), Shanghai Municipal Health Commission (SHWJRS 2021-99), and Shanghai Sailing Program (22YF1408800).

Published in EClinicalMedicine

ISSN: 2589-5370 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://www.thelancet.com/journals/eclinm/home

About the journal

Abstract

Keywords